Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,102 | 59,010 | 71,144 | 67,941 | 58,925 |
| Marketable Securities | 307,024 | 301,384 | 330,171 | 326,999 | 384,752 |
| Receivables | 11,372 | 7,491 | 8,032 | 7,125 | 13,851 |
| TOTAL | $416,185 | $399,907 | $448,445 | $487,397 | $542,425 |
| Non-Current Assets | |||||
| PPE Net | 16,213 | 16,697 | 17,453 | 17,579 | 18,111 |
| Investments And Advances | 2,435 | 3,369 | 3,907 | 3,887 | 3,909 |
| Intangibles | 12,882 | 13,013 | 13,140 | 13,267 | 13,393 |
| Other Non-Current Assets | 11,683 | 12,525 | 12,997 | 13,633 | 14,004 |
| TOTAL | $43,214 | $45,604 | $47,497 | $48,366 | $49,418 |
| Total Assets | $459,399 | $445,511 | $495,942 | $535,763 | $591,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106,354 | 39,523 | 48,193 | 29,147 | 31,869 |
| Accrued Expenses | 10,123 | 11,828 | 10,326 | 13,619 | 10,416 |
| TOTAL | $131,064 | $59,360 | $65,742 | $51,376 | $51,749 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,850 | 5,336 | 4,619 | 6,074 | 7,000 |
| Other Non-Current Liabilities | 30,575 | 30,974 | 30,434 | 30,677 | 31,398 |
| TOTAL | $30,664 | $31,066 | $30,530 | $30,814 | $31,539 |
| Total Liabilities | $161,728 | $90,426 | $96,272 | $82,190 | $83,288 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,775 | 19,079 | 18,110 | 17,525 | 17,523 |
| Common Shares | 248 | 227 | 217 | 210 | 210 |
| Retained earnings | -1,395,601 | -1,287,103 | -1,209,855 | -1,102,908 | -1,042,739 |
| Other shareholders' equity | -649 | -459 | -283 | -258 | -265 |
| TOTAL | $297,671 | $355,085 | $399,669 | $453,572 | $508,554 |
| Total Liabilities And Equity | $459,399 | $445,511 | $495,942 | $535,763 | $591,842 |